West Pharmaceutical Services Inc (WST) stock
WSTNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 20/3032% above fair value
$416.42+5.12 (+1.24%)
Close on Nov 13, 2026Market cap $29.01BP/E 46.7Yield 0.21%
West Pharmaceutical Services operating margin
Operating margin is operating income as a percentage of revenue.
West Pharmaceutical Services's operating margin for the twelve months ending Sep 30, 2026 was 23.0%. For fiscal 2025 it was 19.0%, against 19.7% the year before. The highest annual figure on record is 26.6% in fiscal 2021.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 19.0% | −0.7 |
| FY2024 | Dec 31, 2024 | 19.7% | −3.2 |
| FY2023 | Dec 31, 2023 | 22.9% | −2.5 |
| FY2022 | Dec 31, 2022 | 25.4% | −1.1 |
| FY2021 | Dec 31, 2021 | 26.6% | +7.6 |
| FY2020 | Dec 31, 2020 | 19.0% | +2.8 |
| FY2019 | Dec 31, 2019 | 16.1% | +2.1 |
| FY2018 | Dec 31, 2018 | 14.0% | −0.1 |
| FY2017 | Dec 31, 2017 | 14.1% | +1.2 |
| FY2016 | Dec 31, 2016 | 12.9% | +3.7 |
| FY2015 | Dec 31, 2015 | 9.2% | −3.6 |
| FY2014 | Dec 31, 2014 | 12.8% | +0.9 |
| FY2013 | Dec 31, 2013 | 11.9% | +1.2 |
| FY2012 | Dec 31, 2012 | 10.7% | +1.5 |
| FY2011 | Dec 31, 2011 | 9.2% | +1.0 |
| FY2010 | Dec 31, 2010 | 8.2% | −1.0 |
| FY2009 | Dec 31, 2009 | 9.2% | −2.6 |
| FY2008 | Dec 31, 2008 | 11.8% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 30.6% | +9.7 |
| Q2 FY2026 | Jun 30, 2026 | 20.5% | +0.5 |
| Q1 FY2026 | Mar 31, 2026 | 21.0% | +5.6 |
| Q4 FY2025 | Dec 31, 2025 | 19.5% | −1.9 |
| Q3 FY2025 | Sep 30, 2025 | 20.8% | −0.8 |
| Q2 FY2025 | Jun 30, 2025 | 20.1% | +2.1 |
| Q1 FY2025 | Mar 31, 2025 | 15.3% | −2.3 |
| Q4 FY2024 | Dec 31, 2024 | 21.3% | −0.7 |
| Q3 FY2024 | Sep 30, 2024 | 21.6% | −2.1 |
| Q2 FY2024 | Jun 30, 2024 | 18.0% | −6.2 |
| Q1 FY2024 | Mar 31, 2024 | 17.7% | −4.0 |
| Q4 FY2023 | Dec 31, 2023 | 22.0% | +3.7 |
| Q3 FY2023 | Sep 30, 2023 | 23.7% | −3.4 |
| Q2 FY2023 | Jun 30, 2023 | 24.2% | −5.4 |
| Q1 FY2023 | Mar 31, 2023 | 21.7% | −4.7 |
| Q4 FY2022 | Dec 31, 2022 | 18.3% | −6.9 |
| Q3 FY2022 | Sep 30, 2022 | 27.1% | +1.4 |
| Q2 FY2022 | Jun 30, 2022 | 29.6% | +0.4 |
| Q1 FY2022 | Mar 31, 2022 | 26.3% | +0.2 |
| Q4 FY2021 | Dec 31, 2021 | 25.2% | +5.2 |
| Q3 FY2021 | Sep 30, 2021 | 25.7% | +7.6 |
| Q2 FY2021 | Jun 30, 2021 | 29.2% | +9.6 |
| Q1 FY2021 | Mar 31, 2021 | 26.2% | +8.3 |
| Q4 FY2020 | Dec 31, 2020 | 20.0% | +3.4 |
| Q3 FY2020 | Sep 30, 2020 | 18.1% | +3.3 |
| Q2 FY2020 | Jun 30, 2020 | 19.7% | +2.5 |
| Q1 FY2020 | Mar 31, 2020 | 17.9% | +2.0 |
| Q4 FY2019 | Dec 31, 2019 | 16.6% | +1.0 |
| Q3 FY2019 | Sep 30, 2019 | 14.8% | +0.7 |
| Q2 FY2019 | Jun 30, 2019 | 17.1% | +3.7 |
| Q1 FY2019 | Mar 31, 2019 | 15.9% | +3.1 |
| Q4 FY2018 | Dec 31, 2018 | 15.6% | +1.0 |
| Q3 FY2018 | Sep 30, 2018 | 14.1% | −1.7 |
| Q2 FY2018 | Jun 30, 2018 | 13.5% | +2.9 |
| Q1 FY2018 | Mar 31, 2018 | 12.8% | −2.8 |
| Q4 FY2017 | Dec 31, 2017 | 14.5% | +0.7 |
| Q3 FY2017 | Sep 30, 2017 | 15.8% | – |
| Q2 FY2017 | Jun 30, 2017 | 10.6% | – |
| Q1 FY2017 | Mar 31, 2017 | 15.6% | – |
| Q4 FY2016 | Dec 31, 2016 | 13.8% | – |
See a number that looks wrong?